| For Immediate Release | 02 May 2024 |
Swire Pacific Limited (Swire Pacific or the Company) announced that it has completed the transaction to increase its stake in DeltaHealth China Limited (DeltaHealth). Swire Pacific initially made an associate investment in DeltaHealth in 2021 and signed definitive agreements to increase its stake in March 2024. This latest development marks the Company’s first time as the major shareholder in a healthcare business and aligns with Swire Pacific’s strategy of being a long-term owner and operator of healthcare services.
DeltaHealth comprises a cardiovascular-focused hospital, Shanghai DeltaHealth Hospital, and an outpatient clinic, DeltaWest Clinic, also in Shanghai. DeltaHealth has built up strong core capabilities in cardiovascular care. Shanghai DeltaHealth Hospital ranked first among private hospitals and within the top ten among all hospitals (including public hospitals) in Shanghai in terms of cardiovascular surgery volume in 2023. Aside from cardiovascular care, DeltaHealth has also recently expanded into thoracic surgery and oncology.
Guy Bradley, Chairman of Swire Pacific, said: "We are very excited to be investing further into DeltaHealth and taking a controlling position. Demand for high-quality healthcare is growing rapidly as income and living standards rise, and we anticipate demand for the treatment of cardiovascular disease to increase in line with these developments."
Aside from DeltaHealth, Swire Pacific also has associate investments in Columbia China Healthcare, which owns and operates hospitals and senior housing in the Yangtze River Delta, Shenzhen New Frontier United Family Hospital, which is a private hospital, and HEAL Medical Group, which operates clinics in Hong Kong. Most recently, the Company made an associate investment in Indonesia Healthcare Corporation, Swire Pacific’s first healthcare venture in South East Asia.
About Swire Pacific Limited
Swire Pacific (HKEX: 00019/00087) is a Hong Kong-listed international conglomerate with a diversified portfolio of market-leading businesses. The company has a long history in Greater China, where the name Swire or Taikoo (太 古) has been established for over 150 years. Swire Pacific's strategy is focused on Greater China and South East Asia, where we seek to grow our core businesses of Property, Beverages, and Aviation, as well as new areas of growth, such as healthcare. Swire Pacific is the largest shareholder in two other listed companies in Hong Kong: Swire Properties Limited and Cathay Pacific Airways Limited. Swire Pacific is listed on the Hang Seng Corporate Sustainability Index, the Dow Jones Sustainability Asia Pacific Index and the MSCI All Country World Index (ACWI) ESG Leaders Index.
Visit Swire Pacific’s website at www.swirepacific.com.
Notes to editor:
Please click here to download high-resolution image.
| © Copyright 1996-2024 irasia.com Ltd. All rights reserved. |
|
DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any
information provided on this website. Under no circumstances shall irasia.com Ltd be liable
for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website. |